posted on 2015-09-23, 15:08authored byShengwei Wei, Bernard Schmid, Fliur Z. Macaev, Serghei N Curlat, Andrei MalkovAndrei Malkov, Svetlana B. Tsogoeva
The application of a convenient one-pot synthetic
strategy, utilizing an in situ formed organocatalyst, to
the enantioselective synthesis of anti-leukaemia agent
(R)-convolutamydine A has been demonstrated.
Funding
S.B.T is grateful to the
Interdisciplinary Center for Molecular Materials (ICMM),
Erlangen Catalysis Resource Center (ECRC) and Deutsche
Forschungsgemeinschaft (DFG) for research support.
S.B.T. and F.Z.M. acknowledge financial support from the
BMBF and AȘM (bilateral BMBF-AȘM project Ref. № MDA
08/010 and № 09.820.05.08 GF).
History
School
Science
Department
Chemistry
Published in
Asymmetric Catalysis
Volume
2
Issue
1
Pages
1 - 6 (6)
Citation
WEI, S. ... et al, 2015. One-pot synthesis of (R)-convolutamydine A involving in situ chiral organocatalyst formation. Asymmetric Catalysis, 2 (1), pp. 1 - 6.
This work is made available according to the conditions of the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 Unported (CC BY-NC-ND 3.0) licence. Full details of this licence are available at: http://creativecommons.org/licenses/by-nc-nd/3.0/
Publication date
2015
Notes
This is an Open Access article published by De Gruyter Open and licensed under the Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License.